- Home
- WVE vs MTAL Comparison
WVE vs MTAL Comparison
Compare WVE & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WVE
- MTAL
- Stock Information
- Founded
- WVE 2012
- MTAL 2021
- Country
- WVE Singapore
- MTAL Jersey
- Employees
- WVE N/A
- MTAL N/A
- Industry
- WVE Biotechnology: Pharmaceutical Preparations
- MTAL Blank Checks
- Sector
- WVE Health Care
- MTAL Finance
- Exchange
- WVE Nasdaq
- MTAL Nasdaq
- Market Cap
- WVE 915.6M
- MTAL 994.0M
- IPO Year
- WVE 2015
- MTAL 2021
- Fundamental
- Price
- WVE $6.50
- MTAL $12.09
- Analyst Decision
- WVE Strong Buy
- MTAL Hold
- Analyst Count
- WVE 13
- MTAL 2
- Target Price
- WVE $20.15
- MTAL $12.63
- AVG Volume (30 Days)
- WVE 1.0M
- MTAL 705.2K
- Earning Date
- WVE 08-07-2025
- MTAL 08-09-2025
- Dividend Yield
- WVE N/A
- MTAL N/A
- EPS Growth
- WVE N/A
- MTAL N/A
- EPS
- WVE N/A
- MTAL N/A
- Revenue
- WVE $104,939,000.00
- MTAL $340,736,000.00
- Revenue This Year
- WVE N/A
- MTAL $20.81
- Revenue Next Year
- WVE $1.94
- MTAL $21.10
- P/E Ratio
- WVE N/A
- MTAL N/A
- Revenue Growth
- WVE N/A
- MTAL 114.30
- 52 Week Low
- WVE $4.87
- MTAL $7.69
- 52 Week High
- WVE $16.74
- MTAL $14.93
- Technical
- Relative Strength Index (RSI)
- WVE 45.10
- MTAL 62.80
- Support Level
- WVE $6.67
- MTAL $11.94
- Resistance Level
- WVE $7.10
- MTAL $12.15
- Average True Range (ATR)
- WVE 0.38
- MTAL 0.14
- MACD
- WVE -0.02
- MTAL -0.12
- Stochastic Oscillator
- WVE 7.77
- MTAL 22.12
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
About MTAL Metals Acquisition Limited
MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.